Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $107.85 million. The enterprise value is $141.69 million.

Market Cap	107.85M
Enterprise Value	141.69M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MCRB has 8.73 million shares outstanding. The number of shares has increased by 22.09% in one year.

Current Share Class	8.73M
Shares Outstanding	8.73M
Shares Change (YoY)	+22.09%
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	0.59%
Owned by Institutions (%)	13.04%
Float	6.44M

Valuation Ratios

The trailing PE ratio is 1.38.

PE Ratio	1.38
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.14
P/TBV Ratio	2.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 1.77.

Current Ratio	2.11
Quick Ratio	1.97
Debt / Equity	1.77
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.22%
Return on Invested Capital (ROIC)	-48.44%
Return on Capital Employed (ROCE)	-85.89%
Revenue Per Employee	n/a
Profits Per Employee	$708,262
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.46% in the last 52 weeks. The beta is 2.74, so MCRB's price volatility has been higher than the market average.

Beta (5Y)	2.74
52-Week Price Change	-39.46%
50-Day Moving Average	8.50
200-Day Moving Average	13.73
Relative Strength Index (RSI)	69.50
Average Volume (20 Days)	110,438

Short Selling Information

The latest short interest is 679,397, so 7.78% of the outstanding shares have been sold short.

Short Interest	679,397
Short Previous Month	711,221
Short % of Shares Out	7.78%
Short % of Float	10.56%
Short Ratio (days to cover)	7.85

Income Statement

Revenue	n/a
Gross Profit	-18.06M
Operating Income	-114.11M
Pretax Income	-82.68M
Net Income	72.95M
EBITDA	-109.13M
EBIT	-114.11M
Earnings Per Share (EPS)	$8.98

Full Income Statement

Balance Sheet

The company has $58.85 million in cash and $89.55 million in debt, giving a net cash position of -$30.70 million or -$3.52 per share.

Cash & Cash Equivalents	58.85M
Total Debt	89.55M
Net Cash	-30.70M
Net Cash Per Share	-$3.52
Equity (Book Value)	50.47M
Book Value Per Share	5.78
Working Capital	34.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.46 million and capital expenditures -$352,000, giving a free cash flow of -$86.82 million.

Operating Cash Flow	-86.46M
Capital Expenditures	-352,000
Free Cash Flow	-86.82M
FCF Per Share	-$9.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.09%
Shareholder Yield	-22.09%
Earnings Yield	65.73%
FCF Yield	-78.22%

Analyst Forecast

The average price target for MCRB is $73.67, which is 496.52% higher than the current price. The consensus rating is "Hold".

Price Target	$73.67
Price Target Difference	496.52%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 22, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 22, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2